Shanker Polsani, MD
Fax: (770) 385-4456
Business hours
| Monday | 8:00am to 4:00pm |
| Tuesday | 8:00am to 4:00pm |
| Wednesday | 8:00am to 4:00pm |
| Thursday | 8:00am to 4:00pm |
| Friday | 8:00am to 4:00pm |
| Saturday | - |
| Sunday | - |
About us
Shanker Polsani, M.D., earned his medical degree from Kakatiya Medical College in India. He completed his residency at Louis A. Weiss Memorial Hospital followed by fellowship in Medical Oncology and Hematology at Brody School of Medicine at East Carolina University. He is board certified in Internal Medicine, Medical Oncology and Hematology. Prior to joining Piedmont, Dr. Polsani was Chief Fellow of Hematology and Medical Oncology at Brody School of Medicine and has worked as an Assistant Professor in the Section of Hospital Medicine at Wake Forest Baptist Medical Center in Winston Salem, NC. Dr. Polsani specializes in Medical Oncology and Hematology. Dr. Polsani has a special interest in GI, Thoracic Oncology and Classical Hematology. In his spare time, Dr. Polsani enjoys spending time with his family and friends. He enjoys playing tennis. Dr. Polsani is accepting new patients and welcomes most major insurance plans.
Schedule an Appointment Today!
| Languages | English, Hindi |
| Tags | abdominal cancer, abdominal cancer chemotherapy, abnormal protein, adenocarcinoma of lung, adenocarcinoma of the bladder, adenocarcinoma of the head and neck, adjuvant chemotherapy, adrenal neoplasm, adult t cell leukemia, adult t cell lymphoma, advanced malignancies, adverse effects to anticoagulants, alk negative anaplastic large cell lymphoma, anal cancer, anal cancer chemotherapy, anaplastic cancer of thyroid, anaplastic large cell lymphoma, anemia, anemia and bone marrow disorders, anemia of chronic disease, anemia of pregnancy, anorectal cancer chemotherapy, anticoagulation, antithrombin deficiency, aplastic anemia, appendiceal cancer chemotherapy, aranesp injection, atypical neurofibroma, autoimmune cytopenia, autoimmune lymphoproliferative syndrome (alps), b cell lymphoproliferative disorder, b12 deficiency anemia, biliary tract cancer chemotherapy, bladder cancer, bladder cancer chemotherapy, bladder cancer genomics, blastic plasmacytoid dendritic cell neoplasm, bleeding disorder, blood cancer, blood cancer chemotherapy, blood clot, blood clotting disorder, blood disorders, blood transfusion therapy, bone marrow disorders, bone marrow fibrosis, bone sarcoma, brain cancer chemotherapy, brain cancer genomics, brain metastases, breast cancer, breast cancer biological targeted therapy, breast cancer chemotherapy, breast cancer genetics, breast cancer screening, bronchus associated lymphoid tissue lymphoma, burkitt lymphoma, cancer, cancer chemotherapy, cancer during pregnancy, cancer genomics, cancer immunotherapy, cancer of the joints, cancer of the muscles, cancer pain, cancer rehabilitation, cancer related anxiety disorder, cancer related bereavement disorder, cancer related cognitive disorder, cancer related depression, cancer related fatigue, cancer related psychiatric disorder, cancer related sexual concerns, cancer related stress disorder, cancer risk, cancer survivor, carcinoma of unknown primary, cardiolipin antibody assay, cervical and endometrial cancers, cervical cancer, cervical cancer chemotherapy, cervical cancer genomics, cervical lymphadenopathy, chemoradiation, chronic lymphocytic leukemia], chronic myelocytic leukemia, chronic myelomonocytic leukemia, chronic neutrophilic leukemia, cns lymphoma, coagulation disorders, colon cancer chemotherapy, colon cancer genomics, colorectal cancer chemotherapy, colorectal malignancy, congenital sideroblastic anemia (csa), consolidation chemotherapy, cutaneous b cell lymphoma, cutaneous lymphoma, deep thrombophlebitis, deep vein thrombosis |
| Video | https://www.youtube.com/watch?v=UrS_01quKCc |